Skip to main content

Warfarin


Mechanism

 Warfarin is a commonly used anticoagulant that works by inhibiting synthesis of vitamin K dependent clotting factors (II, VII, IX, and X) and proteins C and S by the liver. Specifically, warfarin inhibits the enzyme vitamin K reductase resulting in inhibition of vitamin-K dependent gamma-carboxylation of glutamic acid residues on clotting factors II, VII, IX and X.



Warfarin takes a few days to start working and it first affects protein C and S production. Because proteins C and S have anticoagulant properties, warfarin, initially results in a temporary increase in the risk of thrombus formation. Therefore, before starting warfarin patients are generally given another anticoagulant such as heparin.

Metabolism

Warfarin is metabolized by cytochrome P450, a microsomal enzyme in the liver.

Reversing the effects of Warfarin

Fresh frozen plasma (FFP) restores vitamin-K dependent clotting factors, making it the quickest way to normalize prothrombin time (PT). Vitamin K administration is a slower method for reversing warfarin toxicity because time is needed for new vitamin-K dependent clotting factors to be made by the liver.

 Warfarin drug interactions and food restrictions

Many medications and supplements interact with warfarin. Generally, cytochrome P450 (CYP450) inhibitors enhance the effect of warfarin and CYP450 inducers reduce the effect of warfarin.
  • CYP450 inhibitors: Acetaminophen, NSAIDs, Antibiotics (e.g. metronidazole, trimethoprim-sulfamethoxazole) and antifungals, Amiodarone, Cimetidine, Cranberry juice, Ginko biloba, vitamin E, Omeprazole, Thyroid hormone, SSRIs
  • CYP450 inducers: Carbamazepine, phenytoin, Ginseng, St. John's wort, Oral contraceptives, Phenobarbital, Rifampin. 
Patients on warfarin have to pay attention to what they eat because foods high in vitamin K will decrease the effect of warfarin. 

Warfarin-induced Skin Necrosis

Within the first few days after starting warfarin, patient develops venous thromboembolism in the skin. Lesions can be found anywhere but are usually seen on the trunk, limbs, breast and penis. At first affected areas become itchy and swollen then necrosis develops. This condition occurs because warfarin when given alone initially results in a pro-coagulant phase due to reduction of the anticoagulants protein C & S production by the liver. There is rapid decline in protein C levels, as much as 50%. Treatment is to stop warfarin and give protein C concentrate. Note: this condition is more likely in patients with hereditary protein C deficiency.










Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Chronic Myeloid Leukemia (CML)

Quick Review Patient is often older, and can no symptoms or have B symptoms (night sweats, etc), fatigue, and weight loss (caused by early satiety due to enlarged spleen). On physical exam, an enlarged spleen can be palpated. CBC shows very high WBC count (typically >100,000) with elevated basophils on differential. Peripheral smear shows early, immature neutrophil precursors (myelocytes, metamyelocytes) as well as many basophils. It is important for CML to know the details of the genetic abnormality because it relates to the treatment. CML is due to a translocation of BCR and ABL on chromosomes 9 and 22 resulting a fusion BCR-ABL gene that produces a tyrosine kinase that is always active. The treatment of choice is a tyrosine kinase inhibitor e.g. imatinib. They work to suppress the tyrosine kinase and can induce disease remission. Relevant Images Immature neutrophil precursors on peripheral smear BCR-ABL translocation
7 comments
Read more

Chemotherapy

Terminology Adjuvant therapy - given in addition to standard therapy Consolidation therapy - given after induction therapy with multidrug regimens to further reduce tumor burden Induction therapy - initial dose of treatment to rapidly kill tumor cells and send the patient into remission Maintenance therapy - given after induction and consolidation therapies or after the initial standard therapy to kill any residual tumor cells and keep the patient in remission Neoadjuvant therapy - given before the standard therapy for a particular disease Remission - less than 5% tumor burden Salvage therapy - given when standard therapy fails Adjuvant therapies in various cancers Metastasis to bone - bisphosphonates (e.g. zoledronic acid) are given to prevent lytic lesions and pathologic fractures as well as malignant hypercalcemia. Bisphosphonates work by inhibiting osteoclasts and thereby preventing bone breakdown. Breast cancer Tamoxifen , a selective estrogen recep...
13 comments
Read more

Heparin

Mechanism Unfractioned heparin (UFH) has a pentasacharide sequence that binds to antithrombin to form a complex. The UFH-antithrombin complex is better at inactivating factor Xa then antithrombin alone. This is because once bound to UFH, antithrombin undergoes a conformational change. The UFH-antithrombin complex can also inactivate thrombin by binding to it. Low moleculer weight heparin (LMWH) also has a pentasaccharide sequence that binds to antithrombin to form a complex. The LMWH-antithrombin complex also inactivates factor Xa, however, it doesn't work on thrombin. This is because the pentasaccharide sequence on LMWH is too short to both complex with antithrombin and bind thrombin. LMWHs typically end in "parin", examples include enoxaparin and dalteparin . Adverse effect:  Heparin-Induced Thrombocytopenia (HIT) Heparin is a common cause of thrombocytopenia. LMWH (e.g. enoxaparin) is less likely than unfractioned heparin to cause HIT.   There are two m...
1 comment
Read more